MabCure, Inc. (MBCI) Research

MabCure, Inc. operates as a development-stage enterprise focused on advancing and commercializing its proprietary antibody technology. This innovative platform is designed for two key applications: the early identification of cancer and the development of targeted therapeutic agents to combat the disease. The company holds exclusive rights to a unique methodology for producing monoclonal antibodies that specifically target desired antigens, including those indicative of various cancers. Established in 2006, MabCure Inc. is based in White Plains, New York. It was originally named Smartec Holdings, Inc., adopting its current name in January 2008 to signify a new strategic business direction.

Market snapshot

Symbol
MBCI
Price
$0.00
Day change
0.00%
Market cap
$14.6K
P/E ratio
-0.00x
52-week range
0.00001-0.0005
Sector
Energy
Industry
Solar

Peer companies

  • BPI Energy Holdings, Inc (BPIGF)
  • Go Solar USA, Inc. (GSLO)
  • iSun, Inc. (ISUNQ)
  • Osage Exploration and Development, Inc. (OEDVQ)
  • Quest Oil Corporation (QOIL)
  • SinglePoint Inc. (SING)
  • Sky Petroleum, Inc. (SKPI)
  • Suburban Minerals Corp. (SUBB)

Recent insider activity

  • Berdugo Gad — A-Award (200000 shares) on 2011-05-19
  • Berdugo Gad — trade (120000 shares) on 2011-09-24
  • KATZ STEVEN — trade (0 shares) on 2008-07-07

Open MabCure, Inc. (MBCI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.